Vacuum-assisted Biopsy Devices Market Research Report 2025 | Image-Guided Biopsy Systems, Breast Biopsy Tools, Minimally Invasive Diagnostic Devices, Surgical Biopsy Instruments

The global Vacuum-assisted Biopsy Devices market size was valued at USD 946.5 million in 2022 and is forecast to a readjusted size of USD 1364.1 million by 2029 with a CAGR of 5.4% during review period.

Introduction: The Revolution in Cancer Diagnosis
The Vacuum-Assisted Biopsy (VAB) Devices Market is set for significant growth in 2025, driven by the rising demand for advanced diagnostic technologies in oncology. As the global healthcare system shifts towards precision medicine and minimally invasive procedures, VAB devices have emerged as a critical tool for accurate tissue sampling. These devices offer significant advantages in biopsy accuracy and patient comfort, especially in the diagnosis of cancers like breast cancer, by extracting larger, more precise tissue samples with minimal patient discomfort.

Market Drivers: Key Factors Fueling Growth
Several pivotal market drivers are shaping the trajectory of the vacuum-assisted biopsy devices market, including increasing disease burden and technological advancements.

• Surge in Cancer Cases Globally
  The rising incidence of breast cancer and other forms of cancer is one of the leading factors driving the demand for vacuum-assisted biopsy devices. As the need for earlier and more accurate diagnosis intensifies, VAB devices offer a reliable method for obtaining tissue samples. According to the World Health Organization (WHO), cancer cases are expected to rise by nearly 70% in the next two decades, fueling the need for advanced diagnostic technologies.
• Preference for Minimally Invasive Procedures
  Minimally invasive procedures are now the preferred choice in diagnostic and therapeutic interventions due to their reduced recovery time, lower risk of complications, and improved patient outcomes. VAB devices, which provide precision tissue sampling through small incisions, align perfectly with these preferences, thereby driving widespread adoption in both developed and emerging markets.
• Technological Advancements and Device Innovation
  The continuous advancement of VAB technology has expanded the capabilities of biopsy devices, improving their accuracy, usability, and integration with imaging tools. The latest innovations include the development of handheld devices, the integration of real-time imaging (e.g., ultrasound and MRI), and smarter needle designs. These innovations increase the efficiency of VAB devices, improving diagnostic accuracy and patient experience.
• Growing Focus on Early Detection and Preventive Care
  With increasing awareness around early disease detection, healthcare systems globally are adopting technologies that can facilitate routine screening and early diagnosis of diseases like breast cancer. VAB devices are critical in this context as they allow for more comprehensive tissue sampling, aiding pathologists in delivering a definitive diagnosis at an earlier stage.

Innovation: Leading-Edge Developments in VAB Technology
Innovation is at the core of the vacuum-assisted biopsy devices market. Continuous advancements in the field have propelled the market forward, with companies and healthcare institutions focusing on enhancing the performance and versatility of these tools.

• Integration with Imaging Technologies
  The integration of imaging technologies with VAB devices has significantly enhanced their precision. For example, the combination of VAB devices with real-time imaging modalities such as ultrasound, CT scans, and MRI enables healthcare professionals to visualize tissue structures in real time. This improves the accuracy of tissue sampling, especially when the biopsy needs to be performed on hard-to-reach or deep-seated tumors.
• Miniaturization and Handheld Devices
  The development of handheld vacuum-assisted biopsy devices has made these tools more accessible, particularly in outpatient clinics and remote healthcare settings. These compact and portable devices allow for quick, accurate biopsies in non-hospital environments, expanding their usability.
• Enhanced Needle Design for Precision
  Recent advancements in needle technology have significantly improved the accuracy and efficiency of VAB procedures. Smaller, more precise biopsy needles reduce the potential for damage to surrounding tissue, minimize patient discomfort, and increase the quality of tissue samples, ensuring more accurate diagnoses.
• Robotic-Assisted Biopsy Systems
  The rise of robotic-assisted biopsy systems is poised to change the landscape of VAB procedures. Robotic assistance ensures better precision, reduced operator error, and the ability to perform complex procedures more safely. These innovations are especially valuable in difficult-to-reach biopsy sites, increasing the versatility of VAB devices in clinical practice.

Regional Market Dynamics: Growth and Opportunities Across Regions
The vacuum-assisted biopsy devices market is experiencing varying levels of growth across different global regions, driven by healthcare infrastructure, cancer prevalence, and regional preferences for diagnostic tools.

• North America: Market Dominance
  North America, particularly the United States, holds a significant share of the VAB devices market, attributed to its advanced healthcare infrastructure, high healthcare expenditure, and strong demand for early cancer diagnosis. The FDA approval of advanced biopsy devices further supports market growth, along with a well-established reimbursement structure for minimally invasive procedures.
• Europe: Expanding Adoption of VAB Devices
  Europe represents another lucrative market, driven by high healthcare standards and regulatory frameworks that encourage early screening and diagnosis. Germany, the UK, and France are leaders in the adoption of VAB technology, owing to their focus on reducing healthcare costs while improving diagnostic outcomes.
• Asia-Pacific: Fast-Growing Market
  The Asia-Pacific region is anticipated to witness the highest growth rate in the coming years. The increasing prevalence of cancer, improving healthcare infrastructure, and growing awareness about early cancer detection in countries like China, India, and Japan make this region a key player. Affordable diagnostic solutions and increasing government initiatives to enhance cancer care are expected to accelerate the adoption of VAB devices.
• Latin America and Middle East & Africa: Emerging Markets
  The Latin America and MEA regions present untapped opportunities for VAB device manufacturers. With improving healthcare systems and an increasing demand for minimally invasive diagnostic techniques, these regions are poised for future growth, particularly as awareness around cancer detection rises.

Strategic Considerations: How Companies Can Leverage Market Opportunities
In this dynamic and rapidly evolving market, companies can adopt several strategies to maximize their growth potential:

• Research & Development Investment
  Continuous innovation and R&D are essential for developing next-generation biopsy devices. Companies should focus on improving device performance, ease of use, and patient comfort to stay ahead of the competition. Partnerships with research institutions and oncology specialists can also accelerate the development of tailored solutions.
• Geographic Expansion
  Expansion into emerging markets, especially in Asia-Pacific and Latin America, presents significant opportunities. Companies can increase their market share by establishing local production facilities, forming strategic partnerships, or entering into distribution agreements to serve the growing demand for advanced diagnostic tools.
• Regulatory Compliance and Certification
  As the global regulatory environment evolves, it is crucial for manufacturers to ensure compliance with industry standards and obtain necessary certifications like FDA approval and CE marking. Regulatory approval ensures market access and instills confidence in healthcare providers and patients.
• Strengthening Post-Sales Support and Training
  Providing ongoing training and support for healthcare professionals is a key factor in ensuring the successful adoption of VAB devices. Companies should focus on offering robust training programs to healthcare providers to optimize the use of these advanced devices and improve patient outcomes.

Conclusion: Future Prospects of the VAB Devices Market
The Vacuum-Assisted Biopsy Devices Market is poised for remarkable growth, driven by technological innovations, increasing cancer prevalence, and the global trend toward minimally invasive procedures. Companies in this market can capitalize on emerging opportunities by focusing on continuous product innovation, regional expansion, and adhering to regulatory standards. As the industry evolves, VAB devices will continue to play a crucial role in enhancing diagnostic accuracy and improving patient outcomes in oncology.

NOTE:

Quants and Trends is proud to offer an extensive portfolio of meticulously researched healthcare market reports, numbering in the thousands. We also provide tailored customization services to ensure our insights align precisely with your strategic objectives and informational needs. For personalized assistance or to discuss your specific requirements, we invite you to get in touch with our team. We also encourage you to request a complimentary sample PDF report. Please visit our Sample Request Page to receive yours today.

   BD
   Mammotome
   Hologic

   9-12G
   Below 9G
   Above 12G

   Hospitals
   Academic and Research Institutes
   Diagnostic and Imaging Centers

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Vacuum-assisted Biopsy Devices Market in 2025?

The strengths include increasing demand for minimally invasive procedures, rising awareness about early cancer detection, and advancements in biopsy technology that make procedures more accurate and less invasive. These devices are also gaining preference in clinical settings due to their ability to collect large tissue samples, improving diagnostic accuracy.

What are the weaknesses in the Vacuum-assisted Biopsy Devices Market in 2025?

The high cost of vacuum-assisted biopsy devices can be a barrier, particularly for healthcare providers in developing regions. Additionally, there might be a lack of trained professionals to handle the technology effectively, which could limit its widespread adoption in certain healthcare settings.

What opportunities exist in the Vacuum-assisted Biopsy Devices Market in 2025?

Opportunities include expanding into emerging markets, where the healthcare infrastructure is improving. There's also potential for innovation in device design and functionality, creating more cost-effective options and enhancing user-friendliness. Furthermore, collaborations with research institutions for advanced diagnostic applications could open up new market avenues.

What threats could impact the Vacuum-assisted Biopsy Devices Market in 2025?

The major threats include the growing competition from alternative biopsy techniques, such as liquid biopsies, that are non-invasive and could replace traditional methods. Additionally, stringent regulatory requirements and the potential for product recalls due to safety concerns could pose challenges to market growth.

How do political factors affect the Vacuum-assisted Biopsy Devices Market in 2025?

Political factors, such as government healthcare policies and reimbursement frameworks, can significantly impact market growth. Supportive policies promoting early cancer detection and funding for advanced medical technologies can boost market demand. However, political instability and changing healthcare regulations could create uncertainties for manufacturers and providers.

What economic factors are influencing the Vacuum-assisted Biopsy Devices Market in 2025?

Economic factors, such as the affordability of healthcare services and the economic stability of a region, can affect market penetration. In developed economies, the increasing demand for advanced medical technologies is boosting growth. However, in developing markets, economic constraints and high device costs may limit adoption.

How do social factors impact the Vacuum-assisted Biopsy Devices Market in 2025?

There is a growing societal focus on preventive healthcare and early diagnosis, which is driving demand for technologies like vacuum-assisted biopsy devices. Additionally, increasing awareness about the benefits of minimally invasive procedures and the rising prevalence of cancer are contributing to market expansion.

What technological factors are shaping the Vacuum-assisted Biopsy Devices Market in 2025?

Technological advancements are playing a crucial role in enhancing the precision, efficiency, and safety of vacuum-assisted biopsy devices. Innovations in device design, such as better tissue sampling mechanisms and improved imaging systems, are making the devices more effective and user-friendly, contributing to wider adoption.

How do environmental factors influence the Vacuum-assisted Biopsy Devices Market in 2025?

Environmental factors, such as sustainability concerns and the demand for eco-friendly medical devices, are influencing product development. Manufacturers may face pressure to adopt environmentally conscious practices in production and packaging, aligning with broader trends toward reducing waste and minimizing environmental impact.

What legal factors could impact the Vacuum-assisted Biopsy Devices Market in 2025?

Legal factors, including stringent medical device regulations, approval processes, and intellectual property laws, can shape the market. Compliance with regulatory standards is critical for market entry and expansion. Additionally, lawsuits or liability issues related to device performance could pose risks to manufacturers and affect market stability.

Who are the suppliers in the Vacuum-assisted Biopsy Devices Market in 2025?

Suppliers in this market include manufacturers of the biopsy devices, raw material providers (such as metals and plastics for device construction), and suppliers of specialized components like needles, vacuum pumps, and imaging technologies. Key players in medical device manufacturing and research organizations are also considered major suppliers.

What inputs are required in the Vacuum-assisted Biopsy Devices Market in 2025?

The inputs required include advanced technologies for imaging and precision cutting, high-quality materials for device construction, research and development for device improvement, and regulatory approvals. Additionally, training programs for healthcare professionals and infrastructure for distribution are essential for market expansion.

Who are the customers in the Vacuum-assisted Biopsy Devices Market in 2025?

Customers primarily include hospitals, diagnostic clinics, cancer treatment centers, and specialized healthcare providers. Other key customers are healthcare providers in emerging markets and research institutions that utilize advanced biopsy technology for studies and trials.

What processes are involved in the Vacuum-assisted Biopsy Devices Market in 2025?

Processes involved include device design and development, clinical trials and regulatory approval, manufacturing and quality assurance, sales and distribution to healthcare facilities, and post-sale support and training for clinicians. Additionally, ongoing research and development to enhance device performance and address market needs is a critical process.

What outputs are generated in the Vacuum-assisted Biopsy Devices Market in 2025?

The primary outputs are advanced vacuum-assisted biopsy devices that are used for accurate tissue sampling. These devices improve diagnostic accuracy and support earlier detection of conditions such as cancer. Additionally, output includes training materials, technical support services, and new innovations in biopsy technology.

How does the threat of new entrants impact the Vacuum-assisted Biopsy Devices Market in 2025?

The threat of new entrants is moderate. While the market offers growth potential, high barriers to entry such as regulatory hurdles, significant R&D investment, and the need for specialized expertise limit the ability of new players to enter. Established brands with strong market presence and patents dominate, making it harder for newcomers to compete.

How does the bargaining power of suppliers affect the Vacuum-assisted Biopsy Devices Market in 2025?

The bargaining power of suppliers is moderate. While there are several suppliers for raw materials and components, specialized components required for high-precision devices are limited, giving suppliers of critical parts some leverage. However, manufacturers can mitigate this by diversifying their supplier base or developing in-house capabilities.

How does the bargaining power of buyers influence the Vacuum-assisted Biopsy Devices Market in 2025?

The bargaining power of buyers is moderate to high. Healthcare providers, especially large hospitals and diagnostic centers, can negotiate for better pricing, given their volume of purchases. However, the highly specialized nature of the devices and their importance in diagnostic accuracy reduce the ability of buyers to easily switch to alternatives.

How intense is the threat of substitute products in the Vacuum-assisted Biopsy Devices Market in 2025?

The threat of substitutes is moderate. While alternatives like traditional core needle biopsies or liquid biopsies exist, vacuum-assisted biopsy devices offer superior tissue sampling quality and minimally invasive benefits, making them a preferred choice. However, advancements in non-invasive diagnostics and alternative biopsy techniques could pose a growing threat.

How competitive is the rivalry among existing players in the Vacuum-assisted Biopsy Devices Market in 2025?

Rivalry among existing players is high. The market is dominated by a few key companies, each investing heavily in R&D and striving to improve device functionality and precision. This competition drives innovation, but also puts pressure on pricing and market share, as players continually push to outperform each other with new features and technologies.

What are the key raw materials required for the Vacuum-assisted Biopsy Devices Market in 2025?

Key raw materials include high-quality metals, plastics, and polymers for the device construction, as well as specialized materials for the needles, vacuum pumps, and imaging systems. Additionally, advanced electronic components are needed for the precise functioning of the devices, along with specialized components for tissue sampling mechanisms.

What are the main suppliers in the upstream value chain for Vacuum-assisted Biopsy Devices in 2025?

The main suppliers in the upstream value chain are manufacturers of medical-grade materials, suppliers of precision components (such as vacuum pumps, needles, and imaging devices), and electronic parts suppliers. Additionally, specialized manufacturers of injection molding and sterilization equipment are involved in the production process.

How does technology affect the upstream value chain of Vacuum-assisted Biopsy Devices in 2025?

Technology plays a significant role by enabling the development of more advanced and precise components, improving production efficiency and reducing costs. Innovations in automation, material science, and 3D printing also streamline the manufacturing of high-quality devices. Continuous R&D in medical technologies will impact the availability and performance of upstream components.

What challenges are faced in the upstream value chain for the Vacuum-assisted Biopsy Devices Market in 2025?

Challenges include the need for continuous innovation to meet the growing demand for more accurate and minimally invasive devices. The high cost of specialized components and stringent regulatory standards can also increase production costs and lead to supply chain complexities. Additionally, sourcing reliable and quality-controlled raw materials remains a key challenge.

What role do regulations play in the upstream value chain for Vacuum-assisted Biopsy Devices in 2025?

Regulations play a critical role by ensuring that all components meet the necessary safety and quality standards. Regulatory approvals for raw materials, manufacturing processes, and finished devices are mandatory, which can slow down production timelines and increase costs. Compliance with global standards also impacts the sourcing and supply chain processes.

What are the key processes involved in the midstream value chain for the Vacuum-assisted Biopsy Devices Market in 2025?

Key processes include the manufacturing of vacuum-assisted biopsy devices, quality control, and testing. After the raw materials are sourced, the devices undergo assembly, calibration, and sterilization before they are packaged. Additionally, processes related to regulatory approvals, certification, and ensuring compliance with industry standards are critical.

How do distribution channels impact the midstream value chain of Vacuum-assisted Biopsy Devices in 2025?

Distribution channels are vital in ensuring that devices reach hospitals, clinics, and diagnostic centers in a timely manner. Efficient logistics, warehousing, and the establishment of a robust supply chain network are essential to maintaining product availability across regions. The distribution process must also adhere to regulations concerning the storage and handling of medical devices.

What are the key players in the midstream segment of the Vacuum-assisted Biopsy Devices Market in 2025?

Key players in the midstream segment are manufacturers of the devices, regulatory bodies that approve medical devices, third-party testing and certification agencies, and logistics and distribution partners. These players work together to ensure that the devices meet safety standards, are produced efficiently, and are available for use by healthcare providers.

What challenges are faced in the midstream value chain for the Vacuum-assisted Biopsy Devices Market in 2025?

Challenges include maintaining quality control while scaling production, ensuring regulatory compliance in multiple markets, and managing the complexities of global distribution networks. The high costs associated with ensuring device safety and efficacy, along with potential delays in getting products through regulatory approvals, can also be problematic.

How does technological advancement affect the midstream value chain of Vacuum-assisted Biopsy Devices in 2025?

Technological advancements in automation and manufacturing processes help improve efficiency and reduce costs during production. Innovations in smart manufacturing, as well as advancements in testing technologies, allow for more accurate quality control. Furthermore, digital tracking and inventory management systems help optimize distribution channels and ensure faster delivery times.

What are the key activities in the downstream value chain for the Vacuum-assisted Biopsy Devices Market in 2025?

Key activities in the downstream value chain include the distribution of finished biopsy devices to healthcare providers, the installation and integration of devices in clinical settings, and the training of medical staff. Post-sales support, maintenance services, and handling customer feedback also play a significant role in ensuring long-term device performance and customer satisfaction.

Who are the main customers in the downstream segment of the Vacuum-assisted Biopsy Devices Market in 2025?

The main customers are hospitals, outpatient clinics, diagnostic centers, oncology centers, and research institutions. These organizations rely on vacuum-assisted biopsy devices for accurate tissue sampling and diagnostic purposes. Additionally, large healthcare networks and private practices involved in cancer detection are key customers in the downstream segment.

What challenges exist in the downstream value chain for the Vacuum-assisted Biopsy Devices Market in 2025?

Challenges in the downstream value chain include ensuring the effective distribution of devices to meet demand in remote or underserved areas. There is also the challenge of training healthcare providers to use the technology effectively and ensuring that maintenance and repair services are readily available. Additionally, managing customer expectations regarding device performance and ensuring consistent product quality can be difficult.

How do regulatory and reimbursement policies affect the downstream value chain of Vacuum-assisted Biopsy Devices in 2025?

Regulatory and reimbursement policies directly impact market access for end customers. The approval of devices by regulatory bodies ensures safety and efficacy, while reimbursement policies influence how widely these devices are adopted in clinical practice. If reimbursement is limited, healthcare providers may be reluctant to invest in these devices, restricting their reach in certain markets.

How does customer feedback influence the downstream value chain of Vacuum-assisted Biopsy Devices in 2025?

Customer feedback plays a crucial role in improving product design and functionality. Positive feedback can strengthen brand loyalty, while negative feedback can push manufacturers to make necessary improvements or updates. Ongoing customer support and responsiveness to feedback are important for long-term relationships and ensuring the devices meet clinical needs effectively.

Chapter 1, to describe Vacuum-assisted Biopsy Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vacuum-assisted Biopsy Devices, with price, sales, revenue and global market share of Vacuum-assisted Biopsy Devices from 2018 to 2023.
Chapter 3, the Vacuum-assisted Biopsy Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vacuum-assisted Biopsy Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Vacuum-assisted Biopsy Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vacuum-assisted Biopsy Devices.
Chapter 14 and 15, to describe Vacuum-assisted Biopsy Devices sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Vacuum-assisted Biopsy Devices
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Vacuum-assisted Biopsy Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 9-12G
       1.3.3 Below 9G
       1.3.4 Above 12G
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Vacuum-assisted Biopsy Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Hospitals
       1.4.3 Academic and Research Institutes
       1.4.4 Diagnostic and Imaging Centers
   1.5 Global Vacuum-assisted Biopsy Devices Market Size & Forecast
       1.5.1 Global Vacuum-assisted Biopsy Devices Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Vacuum-assisted Biopsy Devices Sales Quantity (2018-2029)
       1.5.3 Global Vacuum-assisted Biopsy Devices Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 BD
       2.1.1 BD Details
       2.1.2 BD Major Business
       2.1.3 BD Vacuum-assisted Biopsy Devices Product and Services
       2.1.4 BD Vacuum-assisted Biopsy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 BD Recent Developments/Updates
   2.2 Mammotome
       2.2.1 Mammotome Details
       2.2.2 Mammotome Major Business
       2.2.3 Mammotome Vacuum-assisted Biopsy Devices Product and Services
       2.2.4 Mammotome Vacuum-assisted Biopsy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Mammotome Recent Developments/Updates
   2.3 Hologic
       2.3.1 Hologic Details
       2.3.2 Hologic Major Business
       2.3.3 Hologic Vacuum-assisted Biopsy Devices Product and Services
       2.3.4 Hologic Vacuum-assisted Biopsy Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Hologic Recent Developments/Updates

3 Competitive Environment: Vacuum-assisted Biopsy Devices by Manufacturer

   3.1 Global Vacuum-assisted Biopsy Devices Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Vacuum-assisted Biopsy Devices Revenue by Manufacturer (2018-2023)
   3.3 Global Vacuum-assisted Biopsy Devices Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Vacuum-assisted Biopsy Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Vacuum-assisted Biopsy Devices Manufacturer Market Share in 2022
       3.4.2 Top 6 Vacuum-assisted Biopsy Devices Manufacturer Market Share in 2022
   3.5 Vacuum-assisted Biopsy Devices Market: Overall Company Footprint Analysis
       3.5.1 Vacuum-assisted Biopsy Devices Market: Region Footprint
       3.5.2 Vacuum-assisted Biopsy Devices Market: Company Product Type Footprint
       3.5.3 Vacuum-assisted Biopsy Devices Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Vacuum-assisted Biopsy Devices Market Size by Region
       4.1.1 Global Vacuum-assisted Biopsy Devices Sales Quantity by Region (2018-2029)
       4.1.2 Global Vacuum-assisted Biopsy Devices Consumption Value by Region (2018-2029)
       4.1.3 Global Vacuum-assisted Biopsy Devices Average Price by Region (2018-2029)
   4.2 North America Vacuum-assisted Biopsy Devices Consumption Value (2018-2029)
   4.3 Europe Vacuum-assisted Biopsy Devices Consumption Value (2018-2029)
   4.4 Asia-Pacific Vacuum-assisted Biopsy Devices Consumption Value (2018-2029)
   4.5 South America Vacuum-assisted Biopsy Devices Consumption Value (2018-2029)
   4.6 Middle East and Africa Vacuum-assisted Biopsy Devices Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2029)
   5.2 Global Vacuum-assisted Biopsy Devices Consumption Value by Type (2018-2029)
   5.3 Global Vacuum-assisted Biopsy Devices Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2029)
   6.2 Global Vacuum-assisted Biopsy Devices Consumption Value by Application (2018-2029)
   6.3 Global Vacuum-assisted Biopsy Devices Average Price by Application (2018-2029)

7 North America

   7.1 North America Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2029)
   7.2 North America Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2029)
   7.3 North America Vacuum-assisted Biopsy Devices Market Size by Country
       7.3.1 North America Vacuum-assisted Biopsy Devices Sales Quantity by Country (2018-2029)
       7.3.2 North America Vacuum-assisted Biopsy Devices Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2029)
   8.2 Europe Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2029)
   8.3 Europe Vacuum-assisted Biopsy Devices Market Size by Country
       8.3.1 Europe Vacuum-assisted Biopsy Devices Sales Quantity by Country (2018-2029)
       8.3.2 Europe Vacuum-assisted Biopsy Devices Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Vacuum-assisted Biopsy Devices Market Size by Region
       9.3.1 Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Vacuum-assisted Biopsy Devices Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2029)
   10.2 South America Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2029)
   10.3 South America Vacuum-assisted Biopsy Devices Market Size by Country
       10.3.1 South America Vacuum-assisted Biopsy Devices Sales Quantity by Country (2018-2029)
       10.3.2 South America Vacuum-assisted Biopsy Devices Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Vacuum-assisted Biopsy Devices Market Size by Country
       11.3.1 Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Vacuum-assisted Biopsy Devices Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Vacuum-assisted Biopsy Devices Market Drivers
   12.2 Vacuum-assisted Biopsy Devices Market Restraints
   12.3 Vacuum-assisted Biopsy Devices Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Vacuum-assisted Biopsy Devices and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Vacuum-assisted Biopsy Devices
   13.3 Vacuum-assisted Biopsy Devices Production Process
   13.4 Vacuum-assisted Biopsy Devices Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Vacuum-assisted Biopsy Devices Typical Distributors
   14.3 Vacuum-assisted Biopsy Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Vacuum-assisted Biopsy Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Vacuum-assisted Biopsy Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. BD Basic Information, Manufacturing Base and Competitors
   Table 4. BD Major Business
   Table 5. BD Vacuum-assisted Biopsy Devices Product and Services
   Table 6. BD Vacuum-assisted Biopsy Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. BD Recent Developments/Updates
   Table 8. Mammotome Basic Information, Manufacturing Base and Competitors
   Table 9. Mammotome Major Business
   Table 10. Mammotome Vacuum-assisted Biopsy Devices Product and Services
   Table 11. Mammotome Vacuum-assisted Biopsy Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Mammotome Recent Developments/Updates
   Table 13. Hologic Basic Information, Manufacturing Base and Competitors
   Table 14. Hologic Major Business
   Table 15. Hologic Vacuum-assisted Biopsy Devices Product and Services
   Table 16. Hologic Vacuum-assisted Biopsy Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Hologic Recent Developments/Updates
   Table 18. Global Vacuum-assisted Biopsy Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 19. Global Vacuum-assisted Biopsy Devices Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 20. Global Vacuum-assisted Biopsy Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 21. Market Position of Manufacturers in Vacuum-assisted Biopsy Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 22. Head Office and Vacuum-assisted Biopsy Devices Production Site of Key Manufacturer
   Table 23. Vacuum-assisted Biopsy Devices Market: Company Product Type Footprint
   Table 24. Vacuum-assisted Biopsy Devices Market: Company Product Application Footprint
   Table 25. Vacuum-assisted Biopsy Devices New Market Entrants and Barriers to Market Entry
   Table 26. Vacuum-assisted Biopsy Devices Mergers, Acquisition, Agreements, and Collaborations
   Table 27. Global Vacuum-assisted Biopsy Devices Sales Quantity by Region (2018-2023) & (K Units)
   Table 28. Global Vacuum-assisted Biopsy Devices Sales Quantity by Region (2024-2029) & (K Units)
   Table 29. Global Vacuum-assisted Biopsy Devices Consumption Value by Region (2018-2023) & (USD Million)
   Table 30. Global Vacuum-assisted Biopsy Devices Consumption Value by Region (2024-2029) & (USD Million)
   Table 31. Global Vacuum-assisted Biopsy Devices Average Price by Region (2018-2023) & (USD/Unit)
   Table 32. Global Vacuum-assisted Biopsy Devices Average Price by Region (2024-2029) & (USD/Unit)
   Table 33. Global Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2023) & (K Units)
   Table 34. Global Vacuum-assisted Biopsy Devices Sales Quantity by Type (2024-2029) & (K Units)
   Table 35. Global Vacuum-assisted Biopsy Devices Consumption Value by Type (2018-2023) & (USD Million)
   Table 36. Global Vacuum-assisted Biopsy Devices Consumption Value by Type (2024-2029) & (USD Million)
   Table 37. Global Vacuum-assisted Biopsy Devices Average Price by Type (2018-2023) & (USD/Unit)
   Table 38. Global Vacuum-assisted Biopsy Devices Average Price by Type (2024-2029) & (USD/Unit)
   Table 39. Global Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2023) & (K Units)
   Table 40. Global Vacuum-assisted Biopsy Devices Sales Quantity by Application (2024-2029) & (K Units)
   Table 41. Global Vacuum-assisted Biopsy Devices Consumption Value by Application (2018-2023) & (USD Million)
   Table 42. Global Vacuum-assisted Biopsy Devices Consumption Value by Application (2024-2029) & (USD Million)
   Table 43. Global Vacuum-assisted Biopsy Devices Average Price by Application (2018-2023) & (USD/Unit)
   Table 44. Global Vacuum-assisted Biopsy Devices Average Price by Application (2024-2029) & (USD/Unit)
   Table 45. North America Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2023) & (K Units)
   Table 46. North America Vacuum-assisted Biopsy Devices Sales Quantity by Type (2024-2029) & (K Units)
   Table 47. North America Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2023) & (K Units)
   Table 48. North America Vacuum-assisted Biopsy Devices Sales Quantity by Application (2024-2029) & (K Units)
   Table 49. North America Vacuum-assisted Biopsy Devices Sales Quantity by Country (2018-2023) & (K Units)
   Table 50. North America Vacuum-assisted Biopsy Devices Sales Quantity by Country (2024-2029) & (K Units)
   Table 51. North America Vacuum-assisted Biopsy Devices Consumption Value by Country (2018-2023) & (USD Million)
   Table 52. North America Vacuum-assisted Biopsy Devices Consumption Value by Country (2024-2029) & (USD Million)
   Table 53. Europe Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2023) & (K Units)
   Table 54. Europe Vacuum-assisted Biopsy Devices Sales Quantity by Type (2024-2029) & (K Units)
   Table 55. Europe Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2023) & (K Units)
   Table 56. Europe Vacuum-assisted Biopsy Devices Sales Quantity by Application (2024-2029) & (K Units)
   Table 57. Europe Vacuum-assisted Biopsy Devices Sales Quantity by Country (2018-2023) & (K Units)
   Table 58. Europe Vacuum-assisted Biopsy Devices Sales Quantity by Country (2024-2029) & (K Units)
   Table 59. Europe Vacuum-assisted Biopsy Devices Consumption Value by Country (2018-2023) & (USD Million)
   Table 60. Europe Vacuum-assisted Biopsy Devices Consumption Value by Country (2024-2029) & (USD Million)
   Table 61. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2023) & (K Units)
   Table 62. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Type (2024-2029) & (K Units)
   Table 63. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2023) & (K Units)
   Table 64. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Application (2024-2029) & (K Units)
   Table 65. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Region (2018-2023) & (K Units)
   Table 66. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity by Region (2024-2029) & (K Units)
   Table 67. Asia-Pacific Vacuum-assisted Biopsy Devices Consumption Value by Region (2018-2023) & (USD Million)
   Table 68. Asia-Pacific Vacuum-assisted Biopsy Devices Consumption Value by Region (2024-2029) & (USD Million)
   Table 69. South America Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2023) & (K Units)
   Table 70. South America Vacuum-assisted Biopsy Devices Sales Quantity by Type (2024-2029) & (K Units)
   Table 71. South America Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2023) & (K Units)
   Table 72. South America Vacuum-assisted Biopsy Devices Sales Quantity by Application (2024-2029) & (K Units)
   Table 73. South America Vacuum-assisted Biopsy Devices Sales Quantity by Country (2018-2023) & (K Units)
   Table 74. South America Vacuum-assisted Biopsy Devices Sales Quantity by Country (2024-2029) & (K Units)
   Table 75. South America Vacuum-assisted Biopsy Devices Consumption Value by Country (2018-2023) & (USD Million)
   Table 76. South America Vacuum-assisted Biopsy Devices Consumption Value by Country (2024-2029) & (USD Million)
   Table 77. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Type (2018-2023) & (K Units)
   Table 78. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Type (2024-2029) & (K Units)
   Table 79. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Application (2018-2023) & (K Units)
   Table 80. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Application (2024-2029) & (K Units)
   Table 81. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Region (2018-2023) & (K Units)
   Table 82. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity by Region (2024-2029) & (K Units)
   Table 83. Middle East & Africa Vacuum-assisted Biopsy Devices Consumption Value by Region (2018-2023) & (USD Million)
   Table 84. Middle East & Africa Vacuum-assisted Biopsy Devices Consumption Value by Region (2024-2029) & (USD Million)
   Table 85. Vacuum-assisted Biopsy Devices Raw Material
   Table 86. Key Manufacturers of Vacuum-assisted Biopsy Devices Raw Materials
   Table 87. Vacuum-assisted Biopsy Devices Typical Distributors
   Table 88. Vacuum-assisted Biopsy Devices Typical Customers

List of Figures

   Figure 1. Vacuum-assisted Biopsy Devices Picture
   Figure 2. Global Vacuum-assisted Biopsy Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Vacuum-assisted Biopsy Devices Consumption Value Market Share by Type in 2022
   Figure 4. 9-12G Examples
   Figure 5. Below 9G Examples
   Figure 6. Above 12G Examples
   Figure 7. Global Vacuum-assisted Biopsy Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 8. Global Vacuum-assisted Biopsy Devices Consumption Value Market Share by Application in 2022
   Figure 9. Hospitals Examples
   Figure 10. Academic and Research Institutes Examples
   Figure 11. Diagnostic and Imaging Centers Examples
   Figure 12. Global Vacuum-assisted Biopsy Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Vacuum-assisted Biopsy Devices Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Vacuum-assisted Biopsy Devices Sales Quantity (2018-2029) & (K Units)
   Figure 15. Global Vacuum-assisted Biopsy Devices Average Price (2018-2029) & (USD/Unit)
   Figure 16. Global Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Manufacturer in 2022
   Figure 17. Global Vacuum-assisted Biopsy Devices Consumption Value Market Share by Manufacturer in 2022
   Figure 18. Producer Shipments of Vacuum-assisted Biopsy Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 19. Top 3 Vacuum-assisted Biopsy Devices Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Top 6 Vacuum-assisted Biopsy Devices Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Global Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Region (2018-2029)
   Figure 22. Global Vacuum-assisted Biopsy Devices Consumption Value Market Share by Region (2018-2029)
   Figure 23. North America Vacuum-assisted Biopsy Devices Consumption Value (2018-2029) & (USD Million)
   Figure 24. Europe Vacuum-assisted Biopsy Devices Consumption Value (2018-2029) & (USD Million)
   Figure 25. Asia-Pacific Vacuum-assisted Biopsy Devices Consumption Value (2018-2029) & (USD Million)
   Figure 26. South America Vacuum-assisted Biopsy Devices Consumption Value (2018-2029) & (USD Million)
   Figure 27. Middle East & Africa Vacuum-assisted Biopsy Devices Consumption Value (2018-2029) & (USD Million)
   Figure 28. Global Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 29. Global Vacuum-assisted Biopsy Devices Consumption Value Market Share by Type (2018-2029)
   Figure 30. Global Vacuum-assisted Biopsy Devices Average Price by Type (2018-2029) & (USD/Unit)
   Figure 31. Global Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 32. Global Vacuum-assisted Biopsy Devices Consumption Value Market Share by Application (2018-2029)
   Figure 33. Global Vacuum-assisted Biopsy Devices Average Price by Application (2018-2029) & (USD/Unit)
   Figure 34. North America Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 35. North America Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 36. North America Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Country (2018-2029)
   Figure 37. North America Vacuum-assisted Biopsy Devices Consumption Value Market Share by Country (2018-2029)
   Figure 38. United States Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Canada Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Mexico Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Europe Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 42. Europe Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 43. Europe Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Country (2018-2029)
   Figure 44. Europe Vacuum-assisted Biopsy Devices Consumption Value Market Share by Country (2018-2029)
   Figure 45. Germany Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. France Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. United Kingdom Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Russia Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Italy Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 51. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 52. Asia-Pacific Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Region (2018-2029)
   Figure 53. Asia-Pacific Vacuum-assisted Biopsy Devices Consumption Value Market Share by Region (2018-2029)
   Figure 54. China Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Japan Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Korea Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. India Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Southeast Asia Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Australia Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. South America Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 61. South America Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 62. South America Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Country (2018-2029)
   Figure 63. South America Vacuum-assisted Biopsy Devices Consumption Value Market Share by Country (2018-2029)
   Figure 64. Brazil Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Argentina Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Type (2018-2029)
   Figure 67. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Application (2018-2029)
   Figure 68. Middle East & Africa Vacuum-assisted Biopsy Devices Sales Quantity Market Share by Region (2018-2029)
   Figure 69. Middle East & Africa Vacuum-assisted Biopsy Devices Consumption Value Market Share by Region (2018-2029)
   Figure 70. Turkey Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Egypt Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Saudi Arabia Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. South Africa Vacuum-assisted Biopsy Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. Vacuum-assisted Biopsy Devices Market Drivers
   Figure 75. Vacuum-assisted Biopsy Devices Market Restraints
   Figure 76. Vacuum-assisted Biopsy Devices Market Trends
   Figure 77. Porters Five Forces Analysis
   Figure 78. Manufacturing Cost Structure Analysis of Vacuum-assisted Biopsy Devices in 2022
   Figure 79. Manufacturing Process Analysis of Vacuum-assisted Biopsy Devices
   Figure 80. Vacuum-assisted Biopsy Devices Industrial Chain
   Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 82. Direct Channel Pros & Cons
   Figure 83. Indirect Channel Pros & Cons
   Figure 84. Methodology
   Figure 85. Research Process and Data Source